510(k) · Radiology

Vantage Galan 3T, MRT-3020, V9.0 with AiCE Reconstruction Processing Unit for MR

by Canon Medical Systems Corporation

Vantage Galan 3T, MRT-3020, V9.0 with AiCE Reconstruction Processing Unit for MR is an AI-enabled medical device from Canon Medical Systems Corporation that the U.S. FDA cleared through 510(k) K230355 on August 30, 2023. Its lead review panel is Radiology and its primary product code is LNH (System, Nuclear Magnetic Resonance Imaging).

See also FDA-cleared AI radiology devices in 2023, all FDA AI clearances in 2023, top radiology AI devices.

Key facts

Submission numberK230355
Pathway510(k)
Date of final decision
Company (FDA list)Canon Medical Systems Corporation
Lead review panelRadiology
Primary product codeLNH — System, Nuclear Magnetic Resonance Imaging
Applicant (openFDA)Canon Medical Systems Corporation
Applicant locationOtawara-Shi, JP
Device classClass 2
Regulation number21 CFR 892.1000
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. Vantage Galan 3T, MRT-3020, V9.0 with AiCE Reconstruction Processing Unit for MR went through this pathway (K230355).

openFDA lists it as a Class 2 device under 21 CFR 892.1000. Class II devices are moderate risk and are subject to general and special controls.

Product code LNH covers 100 devices on the FDA AI list. By decision date, this device is #48 of 100 under that code. Canon Medical Systems Corporation has 42 AI-enabled devices on the list, and the Radiology panel accounts for 1,230 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code LNH)

More from Canon Medical Systems Corporation